| Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | AU$ 0.00 | AU$ 5.44M | AU$ 4.02M | AU$ 3.92M | AU$ 5.12M |
| Gross Profit | AU$ -115.54K | AU$ 5.31M | AU$ 3.80M | AU$ 3.63M | AU$ 4.76M |
| Operating Income | AU$ -28.42M | AU$ -14.57M | AU$ -19.60M | AU$ -14.64M | AU$ -15.50M |
| EBITDA | AU$ -28.30M | AU$ -14.63M | AU$ -19.46M | AU$ -17.51M | AU$ -17.39M |
| Net Income | AU$ -23.40M | AU$ -12.15M | AU$ -19.12M | AU$ -13.81M | AU$ -12.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | AU$ 37.32M | AU$ 40.66M | AU$ 12.64M | AU$ 15.77M | AU$ 34.81M |
| Total Assets | AU$ 46.02M | AU$ 46.03M | AU$ 19.22M | AU$ 27.32M | AU$ 41.36M |
| Total Debt | AU$ 193.47K | AU$ 155.46K | AU$ 159.04K | AU$ 210.38K | AU$ 117.49K |
| Net Debt | AU$ -37.12M | AU$ -33.00M | AU$ -12.48M | AU$ -15.56M | AU$ -34.69M |
| Total Liabilities | AU$ 3.29M | AU$ 3.62M | AU$ 5.43M | AU$ 4.50M | AU$ 5.89M |
| Stockholders' Equity | AU$ 42.72M | AU$ 42.40M | AU$ 13.80M | AU$ 22.81M | AU$ 35.47M |
| Cash Flow | |||||
| Free Cash Flow | AU$ 0.00 | AU$ -11.45M | AU$ -12.61M | AU$ -20.04M | AU$ -12.43M |
| Operating Cash Flow | AU$ -22.52M | AU$ -11.45M | AU$ -12.61M | AU$ -20.04M | AU$ -12.34M |
| Investing Cash Flow | AU$ 7.50M | AU$ -7.50M | AU$ -5.72K | AU$ -36.46K | AU$ -89.15K |
| Financing Cash Flow | AU$ 19.13M | AU$ 39.67M | AU$ 9.22M | AU$ 124.34K | AU$ 16.30M |
Alterity Therapeutics (DE:PBN)
FRANKFURT:PBN
